.avma_container { background: #ddd; width: 100%; padding: 0; margin: 0; opacity: 1; display: flex; } .avma_container div{ display: flex; height: 10px; padding: 0; margin: 0; } .item01 { background: #EBF6F7; width: 100%; }
Rodan I. Attract cat clients with friendly handling. Vet Med. 2011;106:486–487.
Rodan I. Understanding feline behavior and application for appropriate handling and management. Top Companion Anim Med. 2010;25(4):178–188.
Mariti C, Bowen JE, Campa S, Grebe G, Sighieri C, Gazzano A. Guardians’ perceptions of cats’ welfare and behavior regarding visiting veterinary clinics. J Appl Anim Welf Sci. 2016;19(4):375–384.
Glardon OJ, Hartnack S, Horisberger L. Analysis of dogs’ and cats’ behavior during the physical examination in veterinary practice [in French]. Schweiz Arch Tierheilkd. 2010;152(2):69–75.
Quimby JM, Smith ML, Lunn KF. Evaluation of the effects of hospital visit stress on physiologic parameters in the cat. J Feline Med Surg. 2011;13(10):733–737.
Anseeuw E, Apker C, Ayscue C, Barker L. Handling cats humanely in the veterinary hospital. J Vet Behav Clin Appl Res 2006;1(2):84–88.
Rodan I, Sundahl E, Carney H, et al. AAFP and ISFM feline-friendly handling guidelines. J Feline Med Surg. 2011;13(15):364–375.
Lloyd JKF. Minimising stress for patients in the veterinary hospital: why it is important and what can be done about it. Vet Sci. 2017;4(2):22. doi: 10.3390/vetsci4020022
Pereira JS, Fragoso S, Beck A, et al. Improving the feline veterinary consultation: the usefulness of Feliway spray in reducing cats’ stress. J Feline Med Surg. 2016;18(12):959–964.
Beata C, Beaumont-Graff E, Coll V, et al. Effect of alpha-casozepine (Zylkene) on anxiety in cats. J Vet Behav Clin Appl Res 2007;2(2):40–46.
Orlando JM, Case BC, Thomson AE, Griffith E, Sherman BL. Use of oral trazodone for sedation in cats: a pilot study. J Feline Med Surg. 2015;18(6):476–482.
Stevens BJ, Frantz EM, Orlando JM, et al. Efficacy of a single dose of trazodone hydrochloride given to cats prior to veterinary visits to reduce signs of transport- and examination-related anxiety. J Am Vet Med Assoc. 2016;249(2):202–207.
Hopfensperger MJ, Messenger KM, Papich MG, Sherman BL. The use of oral transmucosal detomidine hydrochloride gel to facilitate handling in dogs. J Vet Behav Clin Appl Res 2013;8(3):114–123.
Center SA, Elston TH, Rowland PH, et al. Fulminant hepatic failure associated with oral administration of diazepam in 11 cats. J Am Vet Med Assoc. 1996;209(3):618–625.
Martin-Flores M, Mostowy MM, Pittman E, et al. Investigation of associations between preoperative acepromazine or dexmedetomidine administration and development of arterial hypotension or bradycardia in dogs undergoing ovariohysterectomy. J Am Vet Med Assoc. 2019;255(2):193–199.
de-Paris F, Sant’Anna MK, Vianna MRM, et al. Effects of gabapentin on anxiety induced by simulated public speaking. J Psychopharmacol. 2003;17(2):184–188.
Pande AC, Pollack MH, Crockatt J, et al. Placebo-controlled study of gabapentin treatment of panic disorder. J Clin Psychopharmacol. 2000;20(4):467–471.
Ahmed S, Bachu R, Kotapati P, et al. Use of gabapentin in the treatment of substance use and psychiatric disorders: a systematic review. Front Psychiatry. 2019;10:228. doi: 10.3389/fpsyt.2019.00228
Singh L, Field MJ, Ferris P, et al. The antiepileptic agent gabapentin (Neurontin) possesses anxiolytic-like and antinociceptive actions that are reversed by D-serine. Psychopharmacology (Berl). 1996;127(1):1–9.
de-Paris F, Busnello JV, Vianna MRM, et al. The anticonvulsant compound gabapentin possesses anxiolytic but not amnesic effects in rats. Behav Pharmacol. 2000;11(2):169–173.
Pankratz KE, Ferris KK, Griffith EH, Sherman BL. Use of single-dose oral gabapentin to attenuate fear responses in cage-trap confined community cats: a double-blind, placebo-controlled field trial. J Feline Med Surg. 2018;20(6):535–543.
van Haaften KA, Eichstadt Forsythe LR, Stelow EA, Bain MJ. Effects of a single preappointment dose of gabapentin on signs of stress in cats during transportation and veterinary examination. J Am Vet Med Assoc. 2017;251(10):1175–1181.
Stahl SM. Mood stabilizers. In: Stahlapos;s Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. 4th ed. Cambridge University Press; 2013:379.
Gee NS, Brown JP, Dissanayake VU, Offord J, Thurlow R, Woodruff GN. The novel anticonvulsant drug, gabapentin (neurontin), binds to the a2d subunit of a calcium channel. J Biol Chem. 1996;271(10):5768–5776.
Stahl SM. Anticonvulsants as anxiolytics, part 2: pregabalin and gabapentin as a(2)d ligands at voltage-gated calcium channels. J Clin Psychiatry. 2004;65(4):460–461.
Taylor CP, Gee NS, Su TZ, et al. A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res. 1998;29(3):233–249.
Honmou O, Oyelese AA, Kocsis JD. The anticonvulsant gabapentin enhances promoted release of GABA in hippocampus: a field potential analysis. Brain Res. 1995;692(1–2):273–277.
Adrian D, Papich MG, Baynes R, Stafford E, Laxcelles BDX. The pharmacokinetics of gabapentin in cats. J Vet Intern Med. 2018;32(6):1996–2002.
Siao KT, Pypendop BH, Ilkiw JE. Pharmacokinetics of gabapentin in cats. Am J Vet Res. 2010;71(7):817–821.
Thomas WB. Idiopathic epilepsy in dogs and cats. Vet Clin North Am Small Anim Pract. 2010;40(1):161–179.
Dewey CW. Anticonvulsant therapy in dogs and cats. Vet Clin North Am Small Anim Pract. 2006;36(5):1107–1127.
Lorenz ND, Comerford EJ, Iff I. Long-term use of gabapentin for musculoskeletal disease and trauma in three cats. J Feline Med Surg. 2013;15(6):507–512.
Cheng J-K, Chiou L-C. Mechanisms of the antinociceptive action of gabapentin. J Pharmacol Sci. 2006;100(5):471–486.
Steagall PVM, Monteiro-Steagall BP. Multimodal analgesia for perioperative pain in three cats. J Feline Med Surg. 2013;15(8):737–743.
Guedes AGP, Meadows JM, Pypendop BH, Johnson EG, Zaffarano B. Assessment of the effects of gabapentin on activity levels and owner-perceived mobility impairment and quality of life in osteoarthritic geriatric cats. J Am Vet Med Assoc. 2018;253(5):579–585.
Charte Nationale portant sur l’éthique de l’expérimentation animale. Ministère de l’Enseignement Supérieur, de la Recherche et de l’Innovationz. Accessed May 24, 2021. https://www.enseignementsup-recherche.gouv.fr/cid70597/l-utilisation-des-animaux-a-des-fins-scientifiques.html
Integrated development environment for R. RStudio PBC. Accessed August 8, 2020. http://www.rstudio.com
Pratsch L, Mohr N, Palme R. Carrier training cats reduces stress on transport to a veterinary practice. Appl Anim Behav Sci. 2018;206:64–74.

To investigate the effects of a single oral dose of gabapentin on fear-based aggressive behaviors (FABs) in cats during veterinary examinations.
55 healthy pet cats (26 with and 29 without a history of FAB during veterinary visits [FAB and untreated control groups, respectively]).
A standardized 9-step clinical examination protocol (with patient compliance scored from 0 to 9 according to the highest completed step) was tested on untreated control group cats. The protocol was then used in a double-blind, randomized, placebo-controlled, crossover-design trial in which FAB-group cats received owner-administered gabapentin (100 or 200 mg/cat) or placebo capsules 2 hours before the first of 2 veterinary visits and received the alternate treatment before the second visit ≥ 1 day later. Ease of administration (scored from 1 [very difficult] to 4 [very easy]) and adverse effects were recorded. Compliance scores were compared between treatments for the FAB group and between FAB and untreated control groups. Changes in scores between treatments for the FAB group were used to investigate associations between selected variables and the outcome of interest.
FAB group compliance scores after gabapentin administration (median, 9; range, 0 to 9) were significantly higher than scores after placebo administration (median 0.5; range, 0 to 7) and did not differ from scores for the untreated control group. Owner scores indicated capsule administration was easy. Adverse effects (most commonly drowsiness, myorelaxation, and ataxia) resolved ≤ 10 hours after detection.
Results suggested oral administration of gabapentin to cats 2 hours before a veterinary visit can reduce FAB during physical examination, enabling more complete evaluation.
To investigate the effects of a single oral dose of gabapentin on fear-based aggressive behaviors (FABs) in cats during veterinary examinations.
55 healthy pet cats (26 with and 29 without a history of FAB during veterinary visits [FAB and untreated control groups, respectively]).
A standardized 9-step clinical examination protocol (with patient compliance scored from 0 to 9 according to the highest completed step) was tested on untreated control group cats. The protocol was then used in a double-blind, randomized, placebo-controlled, crossover-design trial in which FAB-group cats received owner-administered gabapentin (100 or 200 mg/cat) or placebo capsules 2 hours before the first of 2 veterinary visits and received the alternate treatment before the second visit ≥ 1 day later. Ease of administration (scored from 1 [very difficult] to 4 [very easy]) and adverse effects were recorded. Compliance scores were compared between treatments for the FAB group and between FAB and untreated control groups. Changes in scores between treatments for the FAB group were used to investigate associations between selected variables and the outcome of interest.
FAB group compliance scores after gabapentin administration (median, 9; range, 0 to 9) were significantly higher than scores after placebo administration (median 0.5; range, 0 to 7) and did not differ from scores for the untreated control group. Owner scores indicated capsule administration was easy. Adverse effects (most commonly drowsiness, myorelaxation, and ataxia) resolved ≤ 10 hours after detection.
Results suggested oral administration of gabapentin to cats 2 hours before a veterinary visit can reduce FAB during physical examination, enabling more complete evaluation.

Follow the AVMA journals
Follow the AVMA
AVMA members: Subscribe to newsletters
 
© 2021 American Veterinary Medical Association. All rights reserved.
Powered by KGL PubFactory
Character limit 500/500
Character limit 500/500

source